Skip to main content
. 2009 Jun;174(6):2023–2034. doi: 10.2353/ajpath.2009.080873

Figure 6.

Figure 6

Kaplan-Meier curves of PFS in HER2-positive patients. Note that an absence of stromal Cav-1 immunostaining also predicts poor clinical outcome in HER2-positive patients (P = 7.97 × 10−3, log-rank test), which represents a total of 32 breast cancer patients. 5-year PFS is indicated by an arrow. The status of epithelial Cav-1 is shown for comparison. n.s., denotes not significant.